Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder
El propósito de este estudio es determinar la seguridad y viabilidad de secuenciar la terapia con psilocibina con un protocolo de aiTBS de corta duración (Stanford Accelerated Intelligent Neuromodulation Therapy, o SAINT) en personas con trastorno depresivo mayor resistente al tratamiento.
- Status
- recruiting
- Phase
- Phase 2
- Institution
- University of Texas at Austin
- Principal investigator
- Gregory A Fonzo, Ph.D.
- Start date
- 2025-01-10
- End date
- 2030-12-31
- Registry ID
- NCT06132178
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.